Document is current
Any future updates will be listed below
-
Authors
Carreño, Juan Manuel
Alshammary, Hala
Tcheou, Johnstone
Singh, Gagandeep
Raskin, Ariel J.
Kawabata, Hisaaki
Sominsky, Levy A.
Clark, Jordan J.
Adelsberg, Daniel C. https://orcid.org/0000-0003-0591-7136
Bielak, Dominika A.
Gonzalez-Reiche, Ana Silvia https://orcid.org/0000-0003-3583-4497
Dambrauskas, Nicholas
Vigdorovich, Vladimir https://orcid.org/0000-0003-4195-4858
,
Alburquerque, B.
Amoako, A. A.
Banu, R.
Beach, K. F.
Bermúdez-González, M. C.
Cai, G. Y.
Ceglia, I.
Cognigni, C.
Farrugia, K.
Gleason, C. R.
van de Guchte, A.
Kleiner, G.
Khalil, Z.
Lyttle, N.
Mendez, W. A.
Mulder, L. C. F.
Oostenink, A.
Rooker, A.
Salimbangon, A. T.
Saksena, M.
Paniz-Mondolfi, A. E.
Polanco, J.
Srivastava, Komal
Sather, D. Noah
Sordillo, Emilia Mia https://orcid.org/0000-0001-7787-3051
Bajic, Goran https://orcid.org/0000-0003-0480-4324
van Bakel, Harm https://orcid.org/0000-0002-1376-6916
Simon, Viviana https://orcid.org/0000-0002-6416-5096
Krammer, Florian https://orcid.org/0000-0003-4121-776X
- License Information
-
More Information
Article History
Received: 20 December 2021
Accepted: 31 December 2021
First Online: 31 December 2021
Competing interests
: The Icahn School of Medicine at Mount Sinai has filed patent applications relating to SARS-CoV-2 serological assays (US provisional application numbers: 62/994,252, 63/018,457, 63/020,503 and 63/024,436) and NDV-based SARS-CoV-2 vaccines (US provisional application number: 63/251,020) which list F.K. as co-inventor. V.S. is also listed on the serological assay patent application as co-inventor. Patent applications were submitted by the Icahn School of Medicine at Mount Sinai. Mount Sinai has spun out a company, Kantaro, to market serological tests for SARS-CoV-2. F.K. has consulted for Merck and Pfizer (before 2020), and is currently consulting for Pfizer, Third Rock Ventures, Seqirus and Avimex. The F.K. laboratory is also collaborating with Pfizer on animal models of SARS-CoV-2.
Free to read: This content has been made available to all.
